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Abstract  
Loss of photoreceptors due to retinal degeneration is a major cause of untreatable 
blindness. Cell replacement therapy, using pluripotent stem cell-derived 
photoreceptor cells, may be a feasible future treatment. Achieving safe and effective 
cell replacement is critically dependent on the stringent selection and purification of 
optimal cells for transplantation. Previously, we demonstrated effective 
transplantation of post-mitotic photoreceptor precursor cells labeled by fluorescent 
reporter genes. As genetically-labeled cells are not desirable for therapy, here we 
developed a surface biomarker cell selection strategy for application to complex 
pluripotent stem cell differentiation cultures. We show that a five cell surface 
biomarker panel CD73(+)CD24(+)CD133(+)CD47(+)CD15(-) facilitates the isolation 
of photoreceptor precursors from 3D self-forming retina differentiated from mouse 
embryonic stem cells. Importantly, stem cell-derived cells isolated using the 
biomarker panel successfully integrate and mature into new rod photoreceptors in 
the adult mouse retinae after subretinal transplantation. Conversely, unsorted or 
negatively selected cells do not give rise to newly integrated rods after 
transplantation. The biomarker panel also removes detrimental proliferating cells 
prior to transplantation. Notably, we demonstrate how expression of the biomarker 
panel is conserved in the human retina and propose that a similar selection strategy 
will facilitate isolation of human transplantation-competent cells for therapeutic 
application. 
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Introduction  
Many retinopathies, while variable in their aetiology, share a common end point, the 
loss of rod and cone photoreceptors in the retina [1]. Inherited retinal degenerations 
arise from mutations in one of more than 200 different genes [2]. In the majority of 
cases rod photoreceptors are affected first while loss of cone photoreceptors is 
secondary due to a trophic dependence on the adjacent rods [3]. Worldwide the 
number of people blinded by retinal degenerative conditions, including age related 
macular degeneration is estimated to be more than 3.2 million and is predicted to 
rise as life expectancy increases [4, 5]. Unfortunately, the human retina lacks any 
significant regenerative potential to replace lost photoreceptors; consequently once 
these cells have degenerated the resulting visual impairment is permanent. These 
conditions present a high socio-economic burden for patients, their families, and the 
healthcare system [6]. While significant progress has been achieved over the past 
decade in understanding the underlying molecular mechanisms for a range of retinal 
diseases, current treatment options only delay the onset or decelerate the condition.  
To address the current lack of effective treatments much research effort has been 
focused on the development of novel therapeutic strategies. Cell replacement 
therapy, the reintroduction of healthy photoreceptors into the degenerating retina, 
constitutes such an approach. We and others have previously shown that post-
mitotic, yet immature photoreceptor precursors, derived from a defined time window 
during postnatal development in the mouse can integrate into the existing retinal 
architecture of the normal and diseased adult retina [7-14] and contribute to the 
retinotopic map in the visual cortex [13]. Furthermore, we have demonstrated that 
transplanted rod precursor cells, labeled by the rod-specific Nrl.GFP transgene, can 
significantly improve rod-mediated vision in the Gnat1-/- mouse model of night 
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blindness [13]. The degree of photoreceptor integration appears to be influenced by 
the host environment as different models of retinal degeneration allow varying levels 
of cell incorporation [15].   
Human embryonic stem cells (ESC) and induced pluripotent cells (iPSC) currently 
represent the most feasible sources of cells for future cell therapies as they are 
renewable and can in principle give rise to all somatic cell types. While progress has 
been made in establishing in vitro differentiation protocols for photoreceptor cells, 
most have not yielded sufficient numbers or the appropriate stage for application in 
cell-based therapies [16-19]. Recently, in a landmark study, Sasai and colleagues 
described an embryoid body-based 3D ESC differentiation system, which 
recapitulated many aspects of normal retinal development, sparking the prospect of 
producing sufficient quantities of correctly-staged cells for clinical applications [20, 
21]. Subsequently, we have shown that photoreceptor precursor cells isolated via 
expression of a Rho.GFP transgene from self-forming retinae (generated using an 
adapted Sasai protocol) have the ability to integrate into the healthy and 
degenerating retinal environment in mice [22]. These experiments demonstrated that 
a stem cell-based therapy for retinal dystrophies may in fact be possible by 
combining these new technologies.  
One major obstacle preventing translation to the clinic is the lack of strategies to 
isolate and purify safe and effective cells from complex 3D tissue differentiation 
systems such as those generated from ESC or iPSCs. In these cultures the desired 
target cells are generated in addition to photoreceptors of inappropriate 
developmental stages and other undesired retinal and non-retinal proliferating and 
non-proliferating cell types. While transplantation-competent murine donor cells can 
be isolated relatively effectively from the developing retina via photoreceptor-specific 
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transgene expression [7, 12, 14, 15, 23] a similar genetic manipulation for clinical 
application is undesirable given the potential risks of tumorigenicity associated with 
genetic labelling techniques [24], as well as the need to overcome regulatory hurdles 
associated with combined cell- and gene-based therapies. The use of conjugated 
monoclonal antibodies specific to epitopes on the target cells constitutes an 
alternative to genetic tagging and has already been successfully deployed in clinical 
applications in the areas of cancer biology and immunology [25-27]. Previously, we 
identified two cell surface biomarkers, CD73 and CD24, that in combination labeled a 
(sub)population of postnatal photoreceptor precursor cells, and demonstrated that 
CD73/CD24 positive cells isolated from the postnatal mouse retina integrate 
efficiently into the normal and diseased mouse eye after sub-retinal transplantation 
[28]. CD73/CD24 double-positive rod precursors displayed a significantly higher 
integration potential than unsorted cells, or rod cells isolated using a conventional 
Nrl.GFP transgene. However, our data also indicated that additional markers would 
be necessary for isolation of photoreceptor precursor cells from heterogeneous stem 
cell differentiation cultures due to the broad distribution of individual cell surface 
antigens on non-photoreceptor cells [28]. Therefore, here we developed a cell 
surface biomarker panel of five markers that in combination permits the isolation of 
post-mitotic rod precursors from 3D ESC-derived self-forming retina. We show for 
the first time that ESC-derived rod precursors isolated via a photoreceptor precursor 
biomarker panel can integrate and mature into the normal or diseased adult mouse 
retina. 
 
Material and Methods 
Detailed methods are provided as Supplementary File 1 
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Results  
Identification of cell surface biomarkers for photoreceptors  
To identify a panel of useful cell surface antigens contributing to the characteristic 
biomarker signature of transplantation-competent photoreceptor precursors, defined 
as postnatal day 4-8 (P4-8) [13], we employed a dual approach. First, we examined 
microarray data of the P4 Nrl.GFP retina [28] for enrichment of genes encoding 
cluster of differentiation (CD) markers in the Nrl-expressing rod precursor population 
compared to other retinal cell types. CD markers represent cell surface molecules 
useful for cell immuno-phenotyping and already have widespread clinical application, 
(e.g. selection of bone marrow stem cells for transplantation [29]), due to the 
availability of well-established antibodies. Using a 2-fold cut off to delineate the 
positive and negative cell populations we identified 9 and 25 genes for known mouse 
CD markers that were enriched in rod precursors and other retinal cell types, 
respectively. An additional 60 CD marker genes were expressed in both populations 
in the P4 mouse retina (Supplementary Table 1). 
In a second approach, we used flow-cytometry to screen postnatal retinal cells 
from Nrl.GFP mice with a panel of 174 well characterized monoclonal antibodies (BD 
Lyoplate screening panel) to CD markers and identified 15 expressed antigens (>2% 
in population; Supplementary Fig1A,B). A small number of markers labeled subsets 
of non-Nrl.GFP cells (e.g. CD309, CD200, CD15 and CD90), while the majority of 
cell surface antigens were common between retinal cell populations (Supplementary 
Fig1A,B). CD133 and CD73 intensely labeled Nrl.GFP cells compared to non-
Nrl.GFP cells. Comparison of protein expression seen in the lyoplate screen to the 
respective mRNA levels of CD marker genes observed in the microarray analysis 
Page 7 of 59
 8 
(Supplementary Table 1) showed a widespread congruence, validating gene 
expression analysis as a useful means of identifying biomarkers for cell selection. 
 
FACS analysis of the PPr biomarker panel during retinal development 
We, and others, previously established that CD73 is photoreceptor-specific in the 
context of the developing retina, yet it also labels many other cell types, for example, 
mesenchymal stem cells [9, 28, 30]. Furthermore, CD73 is strongly expressed in 
late-stage and mature photoreceptors, which have poor transplantation efficiency 
and would therefore not be useful as a sole selection tool [12, 28]. To increase 
specificity, we examined CD73 co-labelling with additional CD markers. Based on 
their high expression levels in transplantation-competent Nrl.GFP rod precursors, we 
selected CD47 and CD133, together with CD73 and CD24, to test as a biomarker 
signature for positive cell selection (Supplementary Fig1A,B; in B, top right-hand 
quadrants of scatter plots show CD marker and Nrl.GFP co-labeled cells). All of the 
CD markers we identified on photoreceptor cells, are known to be expressed on 
other cell types, but no cell type has previously been defined as expressing this 
combination of CD markers [CD73(+)CD24(+)CD133(+)CD47(+)] together. To 
remove potentially harmful mitotically-active cells we utilised the retinal progenitor 
marker CD15 [31-33] for negative selection, which, as expected, did not show co-
labeling of Nrl.GFP (Supplementary Fig1A, B). Henceforth, the combination of 
CD73(+), CD24(+), CD133(+), CD47(+) and CD15 (-) is referred to as the 
photoreceptor precursor (PPr) biomarker panel.   
The PPr biomarker panel displayed a dynamic expression profile during the 
course of retinal histogenesis in flow cytometry analyses (Fig1A,B). At embryonic 
day 15 (E15) the proportion of cells expressing all four positive selection markers 
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(CD73, CD133, CD24 and CD47) was 3.5% ± 0.1 (Fig.1B; n=3), due to the low 
number of CD73 positive photoreceptors in the retina at this point. Over the next few 
days the proportion of CD73 positive cells increased resulting in an overall co-
labelling of 17.9% ± 4.1 (Fig.1B; n=3) for the PPr marker panel at P4, which also 
represented the peak of co-expression of the biomarkers during retinal development. 
Among the CD73/CD133 double-positive cell population, which delineates the 
developing rods, CD24 and CD47, both markers of immature retinal cells, were also 
strongly expressed labelling 57.2% ± 17.5 and 96.3% ± 2.3 of the CD73/CD133 
double positive population, respectively, at P4 (n=3; see Fig.1A for representative 
example). Subsequent developmental stages saw a reduction in the number of PPr 
panel-positive cells, with 10.9% ± 0.6 (Fig.1B; n=3) staining at P8 and only 6% ± 3.3 
at P10 (Fig.1B; n=3). The decrease in co-labelling mainly occurred due to the down-
regulation of CD24 in maturing retinal neurons. While CD47 expression was 
maintained at P10, it was then rapidly down-regulated and absent in mature 
photoreceptors (Supplementary Fig.2A). In a separate set of experiments, co-
labelling for CD15 and CD73 showed that these two cell populations are mutually 
exclusive during retinal development indicating that CD15 can be used to remove 
progenitor cells from cell mixes (Fig.1C). qRT-PCR and immunohistochemical 
analysis was also performed on developing retinal samples and showed similar 
trends of biomarker expression (Supplementary Figure 2B, C). Taken together our 
data demonstrate that the PPr marker biomarker panel effectively labels developing, 
but not mature rod photoreceptors (Fig.1D).   
 
Characterization of PPr biomarkers in 3D mESC differentiation cultures 
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Photoreceptor precursors can be generated efficiently using a previously described 
embryoid body-based 3D mouse ESC (mESC) differentiation system [20, 22]. In this 
culture system continuous neuroepithelia are readily produced within 5 days of 
differentiation and optic vesicle-like structures appear around day 7-9 (Fig.2 shows 
optic vesicle neuroepithelium at day 12). Retinal cell genesis proceeds in a 
sequence similar to normal retinal development with all neural retinal cell types being 
present and correctly organised in layers by day 29 of the differentiation procedure, a 
stage which has been shown to correlate with P4-8 during mouse retinal 
development [22].  
Consistent with previous observations, we found that at day 12 of differentiation in 
vitro retinal epithelia showed widespread expression of retinal progenitor markers 
Pax6 and Vsx2 (Fig.2A,B), suggesting an immature state at this point. By day 27, the 
majority of cells within the retinal epithelium labeled with the rod markers Rhodopsin 
and Recoverin and displayed typical photoreceptor morphology (Fig.2C,D). Markers 
of advanced photoreceptor differentiation, such as rod α-Transducin and Peripherin 
2, were only observed in a few photoreceptors at this point (Fig.2E, F). We assessed 
the expression profiles of PPr biomarker transcripts in this system using quantitative 
real-time PCR. Expression of all biomarkers could be detected in undifferentiated 
mESC cultures albeit at relatively low levels. During the retinal differentiation 
procedure, transcript levels of CD24, CD133, CD47 and CD15 increased from day 0 
to day 12, while CD73 transcript levels were significantly increased by day 28; CD24 
levels then declined by day 36 (Fig.2G). We also used an adeno-associated viral 
vector (pseudotype 2/9) carrying a GFP reporter under the control of a Rhodopsin 
promoter (Rhop.GFP) to label rod photoreceptors [22]. Importantly, real-time PCR 
on FAC-sorted Rhop.GFP-positive cells isolated at day 26 of culture confirmed 
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CD73, CD24, CD133 and CD47 expression in the rod population, whilst negligible 
levels of CD15 were detected (Fig.2H). 
Next, we determined the spatial distribution of the proteins encoded by CD73, 
CD133, CD24 and CD47 using immunohistochemistry on tissue sections from early 
and late ESC differentiation cultures (Fig.2I-T). CD73 protein was not detected in 
early retinal epithelia at day 12 of differentiation but showed intense staining 
throughout the photoreceptor layer of in vitro retinae at day 28 and day 36, co-
labelling with rod specific marker Rhodopsin and pan photoreceptor marker 
Recoverin. CD133, CD24 and CD47 showed a similar wide distribution across the 
retina during both early (day 12) and later (day 28) stages of differentiation, including 
the photoreceptor layer, and showed overlap with Rhodopsin and Recoverin signals. 
By day 36, CD24 co-labelling with Rhodopsin and Recoverin appeared reduced 
compared with earlier stages, and compared with the level of co-labelling observed 
for CD73, and CD133  (Fig 2K', N', Q'). In addition to the broad cell surface staining 
also observed with CD24 and CD47, CD133 displayed intense foci of immune-
reactivity at the apical surface of the epithelium (Fig.2I; white arrowhead), similar to 
the pattern detected in late postnatal stages [28].  
Taken together, these different components of the PPr biomarker panel are 
present at both transcript and protein levels in retinal differentiation cultures of mESC 
and exhibit an expression profile broadly consistent with that observed in the 
developing post-natal mouse retina. 
 
FACS profile of PPr biomarkers during retinal differentiation in 3D cultures 
We next established the percentage of cells labeled by each cell surface antigen at 
different times of the retinal differentiation protocol, by performing FACS analysis 
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using fluorochrome-conjugated antibodies (Fig.3A). In undifferentiated (day 0) mESC 
cultures CD73 weakly, but consistently, labeled a small number of cells. Labelling 
then increased significantly to 4.1% ± 2.7 at day 12, and 40% ± 7.9 at day 27 of 
differentiation consistent with onset of photoreceptor genesis in the in vitro retinae 
between the two later time points. In contrast, CD24 labeled most if not all cells at 
day 0 and displayed a slight decrease at subsequent stages of differentiation. CD133 
and CD47 displayed a similar staining profile, labelling only a small proportion of 
cells at the start of the protocol (14.9% ± 8.2 and 18.1% ± 4.9 respectively) and 
increasing over time to 68.5% ± 21.4 and 81.8% ± 12.5 respectively, at day 27. 
These data suggest that no single marker would be sufficient to effectively isolate 
pure and stage-specific photoreceptor precursors for the purpose of retinal stem cell 
therapy.  
We next investigated if, in combination, the cell surface biomarkers could be used 
to isolate cells displaying the typical photoreceptor precursor signature from the 
differentiation cultures at day 0, 12 and 27. As expected, at day 0 the number of cells 
expressing the PPr biomarker panel was minute (0.6% ± 0.1 at d0 and 1.2% ± 0.6 at 
d12, respectively). However, at day 27 of culture 24.6% ± 6.5 of all cells in the in 
vitro retinae were positive for the PPr marker combination (Fig.3B). Conversely, the 
retinal progenitor marker CD15 did not co-label with CD73 (Fig.3B), indicating that 
this marker would enhance removal of potential harmful cells prior to transplantation.  
The distribution of CD markers is usually not restricted to one particular tissue or 
cell type. We therefore confirmed the identity of the PPr biomarker panel-positive 
cells generated in the 3D retinal culture system using immuno-cytochemistry (Fig.4A, 
B). Day 27 retina were dissociated and plated on coverslips to allow investigation of 
colocalisation of CD73 with Rhodopsin or Recoverin on a single cell basis. 
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Rhodopsin and Recoverin were selected as indicators of photoreceptor cell identity 
with robust available antibodies. We observed that 36.3%±14.4 (n=3) of the cells 
labeled with CD73. As expected, the majority of CD73 positive cells were also 
strongly co-labeled with the rod pigment rhodopsin (78.3% ± 10.5; n= 3), confirming 
the rod photoreceptor identity of PPr biomarker labeled cells generated in the day 27 
ESC-derived retina. Similar analysis conducted using Recoverin showed co-labelling 
of 41% ± 13.6 (n=3) of the CD73 positive cells. 
Of the total ESC-derived population, 45% ± 17.8 (n=3) showed Rhodopsin 
staining, confirming a robust and reproducible production of rod photoreceptors in 
this system. Approximately half of the total Rhodopsin-positive cells, expressed 
CD73 (49.4% ± 22.1) indicating the presence of photoreceptor precursors at different 
stages of development. Of the total ESC-derived population, 16.2% ± 7.1 (n=3) 
stained with Recoverin, with the majority of these Recoverin-expressing cells 
showing strong CD73 staining (92.9% ± 10.4; n=3).  
We also performed immunostaining on cells plated after FACS selection using the 
PPr biomarker panel (CD+) compared with CD- and unsorted cells from day 27 ESC-
derived cultures. Enrichment for Crx, Rhodopsin and Recoverin-positive cells was 
observed in the CD+ population (Figure 4C). Yields of PPr sorted CD+ cells ranged 
from 0.41 - 4.89 % of ESC cultures at day 27 (n=3) with a viability of 80%-90%. 
Together, these data indicate that the PPr biomarker panel is useful for the isolation 
of stage-specific rod photoreceptor cells from ESC-derived 3D retinal cultures.  
 
Exclusion of mitotically active cells via PPr selection 
Inclusion of undifferentiated pluripotent stem cells or other proliferating cell 
populations in cell preparations destined for transplantation presents a serious 
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challenge due to their propensity to result in uncontrolled growth and, in the worst 
case scenario, elicit the development of tumours [19, 34, 35]. It is essential that such 
cells be removed prior to transplantation to not only eliminate the risk of tumour 
formation but also increase integration efficiency of genuine photoreceptors as well 
as to prevent any permanent retinal detachment that could arise from cell masses in 
the sub-retinal space [13].  
 At day 27, a small number (<2%; n=3) of cells incorporated EdU during S-
phase and 3.25% labeled with Ki67 (n=1) suggesting that this 3D retinal 
differentiation protocol is generally effective in promoting exit from cell cycle (Fig.5A). 
Nevertheless, because of inherent variability within culture preparations, further 
safeguards to stringently select against any persisting proliferative cells will be 
required. To test the ability of the PPr biomarker panel to remove mitotically active 
cells under challenging conditions (i.e. incomplete, less efficient differentiation) we 
added undifferentiated mouse embryonic stem cells (15%) to dissociated day 26 
retinal cultures and determined the number of mitotic cells after FAC-sorting. No 
overlap was observed between EdU labelling and PPr biomarker selected cells (data 
not shown). However, we found that EdU labelling in combination with the five 
fluorochrome conjugated antibodies to the PPr biomarker panel was not very robust 
due to limitations in the detection system, therefore Ki67 antibody was used as an 
alternative quantitative labelling approach for mitotic cells. In these experiments, 21 
± 6.6% (n=3) of unsorted cells from the combined cell population (~15% 
undifferentiated ESC: 85% day 27 retinal cultures) showed Ki67 (+) staining (Fig.5B, 
C). Cells selected from this proliferative population via co-labelling with CD73+, 
CD24+, CD133+, CD47+, CD15- (CD+) contained only a very small number of 
Ki67(+) dividing cells (0.5% ± 0.23; n=3), demonstrating the effectiveness of the 
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biomarker panel even in the presence of contaminating, undifferentiated cells. On 
the other hand, a high proportion of proliferating cells were observed in the CD- 
population (46 ± 16.5; Fig.5B, C). These data demonstrate that mitotically-active 
cells are efficiently eliminated from donor cell populations, prior to transplantation, by 
using the combination of PPr cell surface biomarkers.   
 
Transplantation of mESC derived photoreceptors 
We next examined the transplantation potential of photoreceptors isolated via the 
PPr biomarker panel from mESC 3D retinal differentiation cultures. To this end, in a 
series of experiments, we transplanted 200,000 PPr biomarker FAC-sorted ESC-
derived rod precursors into the subretinal space of adult wild type, and Gnat1-/- mice 
in which rods are non-functional due to the absence of the rod α−Transducin protein, 
pivotal to the phototransduction cascade [36]. ESC-derived rod precursors were 
sorted at day 27 of 3D retinal differentiation, based on their co-expression of the five 
specific PPr cell surface biomarkers CD73(+) CD24(+) CD133(+) CD47(+) CD15(-). 
Two methods were used in order to identify ESC-derived cells after transplantation. 
Either wEBs were infected with AAV2/9.CMV.GFP virus several days prior to the 
experiment, or, alternatively a transgenic mouse ESC line (CBA.YFP ESC; ATCC-
R), with a YFP reporter cassette driven by the ubiquitously active beta-actin 
promoter was used. 
 Photoreceptors derived from both ESC lines, and selected via PPr biomarker 
expression (CD+) integrated into the adult mouse retina after subretinal injection 
(Fig.6A-E; Supplementary Fig.3). Three weeks post transplantation GFP/YFP 
labeled cells, with single nuclei and displaying the characteristic rod morphology, 
were readily visible within the outer nuclear layer (ONL) of recipient mice and were 
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frequently found in small clusters near the injection site (Fig.6). Rod α−Transducin 
(Gnat-1) immunostaining was detected in the outer segments of GFP-labeled cells 
integrated into ONL of wild type and in the Gnat-deficient recipient retina (Fig.6A, C; 
Supplementary Fig.3). In the latter, we observed clear and robust expression of the 
outer segment protein (Gnat-1) that was missing in the endogenous rods in the 
knock out model. The YFP/GFP-labeled cells displayed typical rod features such as 
segment formation and spherical synaptic connections in the outer plexiform layer. 
Furthermore, integrated cells were Recoverin (Fig.6B) and Rhodopsin positive but 
did not stain with cone-specific markers such as RxRγ, sw-opsin and mw-opsin (data 
not shown) demonstrating a rod identity of incorporated cells. Transplantations of 
cells selected via PPr biomarker expression (CD+) from the mouse postnatal day 8 
(P8) Nrl.GFP retina similarly showed integration of GFP+ cells within the recipient 
wild type ONL three weeks later (Supplementary Figure 3). We evaluated the 
efficiency of transplantation using the PPr biomarker selected ESC-derived 
photoreceptor precursors by counting the number of new GFP-labeled cells 
integrated within the recipient ONL. The transgenic mouse ESC line (CBA.YFP), 
rather than viral labelling, was used for quantification experiments as contaminating 
viral particles could hypothetically label host photoreceptors [22]. Indeed, in 
experiments using AAV2/9.CMV.GFP virus, we observed a large number of 
integrated GFP-labeled cells did not co-label with Gnat-1, suggesting that either 
some integrated cells had not yet acquired a mature differentiation state, which can 
take many days [14], or that a proportion of GFP+ cells were a product of viral 
labelling of host cells (data not shown). 
We found that transplantation of the PPr biomarker positive CBA.YFP ESC-
derived photoreceptor precursors resulted in integration levels significantly higher 
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than unsorted cells (Fig.6G; median for CD+ = 654 cells, range of total number of 
integrated cells per retina = 315 - 1068, N=7), and similar to those previously 
reported with virally-labeled Rhop.GFP ESC-derived rods [22]. By contrast, 
transplantation of biomarker negative cells (CD-), or unsorted day 27 ESC cultures 
demonstrated only poor integration abilities (Fig.6F; median for CD- = 9 cells, range 
0 - 204, N=6; median for unsorted day 27 cultures cells = 60, range 0 - 80, N=6). We 
observed integration levels for P8 PPr biomarker positive cells similar to those for 
ESC-derived PPr biomarker positive cells (median = 210 cells, range 22 - 3039 
N=9). In all ESC transplants, non-integrated GFP+ ESC-derived cells typically 
persisted in the subretinal space 3 weeks after injection (Supplementary Fig.3C 
shows cells in subretinal space in low magnification view of Fig.6E). In transplants of 
biomarker negative cells (CD-) we frequently observed large sub-retinal cell masses 
that contained unidentified cell types of diverse morphologies (Fig.6F) but little or no 
integration. Immmunostaining for Pax6 and GFAP, markers of immature neurons 
and glial cells respectively, and Ki67 for mitotically active cells, did not label 
significant numbers of cells in the PPr biomarker panel negative sub-retinal cell 
masses at 3 weeks post transplantation (data not shown). Taken together, these 
data demonstrate that FAC-sorted ESC-derived rod precursors selected via the PPr 
biomarker panel from dissociated synthetic retinae can integrate effectively, and 
significantly more efficiently than the unsorted ESC-derived cells or PPr biomarker 
negative populations. 
 
Conservation of biomarkers in the developing and mature human retina 
To test the usefulness of the biomarker panel for clinical application we investigated 
the expression of CD73, CD133, CD24 and CD47 in the human retina. RT-PCR 
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revealed CD24 and CD47 were abundantly expressed even at the early stages of 
retinal development (8wks gestation) and, in contrast to the murine retina, remained 
at similar levels in the mature tissue (Fig.7A). CD133 was expressed at low levels 
during weeks 9, 10 and 11 but increased thereafter and was strongly expressed at 
the adult stage. In contrast, CD73 mRNA was not detected until 12wk of gestation 
and was present at all subsequent stages of development and in the mature retina.  
In order to establish the spatial distribution of the biomarker proteins we 
performed immunohistochemistry on cryo-sections prepared from human fetal and 
adult retinal tissue. At 10, 13 and 19wk of gestation, CD24 and CD47 proteins were 
detected in all retinal layers (Fig.7B; Supplementary Fig.4) including the developing 
outer nuclear layer, which contained CRX and RECOVERIN positive photoreceptor 
precursor cells. While CD73 transcript was present from 12wk onwards, no 
immunostaining was observed during the fetal stages, suggesting a post-
transcriptional control mechanism. In contrast, CD133 protein was visible starting 
from 10wks in a punctate pattern at the apical surface of the retina, abutting the 
interface with the retinal pigmented epithelium. qRT-PCR analysis of expression of 
the PPr biomarker panel genes in human retinal samples showed expression of 
CD47 and CD24 during fetal stages, but decreased expression in the mature retina 
(Supplementary Figure 4B), in line with the reduced labelling of mature 
photoreceptors by these markers in the human and mouse retina (Supplementary 
Figure 4A, Supplementary Figure 2).  
While CD73 protein appeared to be absent in the native fetal human retina, a 
small number of CD73 immuno-positive cells were observed in differentiation 
cultures derived from 14wk old primary retinal cells (Fig.7C). Approximately 6% of 
cells in these primary cultures co-labeled with CD73 and CD133 in FACS analysis, 
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whereas 39.4 ± 4.76% of cells in the adult human retina were positive for this dual 
marker combination (Fig.7D). The total number of cells in the adult retina labelling 
with CD73 was 74 ± 4.7%, consistent with the total number of photoreceptors 
(Fig.7D). Furthermore, in immunocytochemical analysis of dissociated retinal cells all 
CD73 positive cells in the adult human retina co-expressed Recoverin, indicating a 
photoreceptor identity (Fig.7E).   
Taken together, our findings demonstrate that the expression patterns and relative 
onset of biomarker expression with respect to retinal differentiation is similar 
between mouse and human. The lack of available human fetal tissue beyond 19wk 
of gestation prevented us from pinpointing the exact onset of CD73 protein 
expression in the human retina; most rod photoreceptors are generated after 19 wks. 
However, our observations are consistent with findings in the murine retina, which 
showed onset of CD73 protein expression in the postnatal time period when the 
majority of the rod photoreceptors are born and then sustained expression in 
photoreceptors.  
 
Discussion 
Cell replacement therapy for retinal disease is a very promising therapeutic strategy 
currently under investigation, the goal of which is the transplantation of stem cell-
derived cells into the diseased retina, either to substitute photoreceptor cells lost 
through the disease process and replace disease genes, or to delay or prevent the 
loss of the remaining cells [37, 38]. We and others have demonstrated that 
photoreceptor precursors can be introduced into the normal and degenerating rodent 
retina via sub-retinal injection and that transplanted rods make appropriate synaptic 
connections to the remaining inner retinal cells [7-10, 15]. Furthermore, correctly 
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integrated cells have been shown to confer low light visual function in a mouse 
model of retinal degeneration and signals generated by these cells were projected to 
visual processing areas in the brain [13].  
The most promising sources of donor cells for a future therapeutic application are 
hESCs and iPSCs; however, the successful translation of this approach to the clinic 
is critically dependent on the development of methods for the isolation and 
purification of optimal stage precursor cells. The use of mixed cell populations 
carries the risk of tumorigenesis due to the presence of mitotically active stem cells, 
and even inappropriately staged photoreceptors reduce integration efficiency and 
therefore would result in a suboptimal clinical outcome. It is therefore critical that a 
cell selection strategy should enable the specific isolation of wild type cells, which 
are committed to the photoreceptor lineage, but which have not yet fully matured, as 
well as excluding proliferating cells.  
In order to meet the need for stringent cell selection and avoiding genetic 
manipulation of cells, we have developed a panel of five useful photoreceptor 
biomarkers that can be effectively utilised to isolate transplantation-competent rod 
precursors from 3D retinal differentiation cultures of mESC. In this study we utilised 
existing CD markers for which fluorochrome-conjugated antibodies already exist far 
application in FACS protocols. Although we have not formally proved that all five 
selected CD markers are necessary and sufficient, this study demonstrates for the 
first time the successful application of a CD marker signature for isolation of 
photoreceptor precursors from differentiated ESCs. In future work it may be possible 
to develop antibodies suitable for FACs for additional markers identified in 
photoreceptors by microarray analysis [28, 39]. We selected CD73 and CD133 to 
confer photoreceptor specificity in the context of ESC-derived retinal differentiation 
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cultures and CD24 and CD47 to enrich for cells equivalent to young, postnatal cells. 
In addition CD15 (SSEA-1) was included for negative cell selection. We showed that 
the biomarkers for positive cell selection (CD73, CD133, CD24 and CD47) have a 
peak of co-expression that correlates with the window of transplantation competence 
(P4-P8) for donor cells isolated from the developing retina. Importantly, the 
expression of individual biomarkers in mESC differentiation cultures followed the 
same pattern seen in the developing retina, with 25% of cells in day 27 cultures 
displaying the biomarker signature of transplantation-competent rod precursors. The 
majority of CD73-expressing cells (~85%) in day 27 cultures co-labeled with the rod 
marker Rhodopsin. Our data indicate that the PPr biomarker selection panel strongly 
enriches for immature photoreceptors in the context of this very heterogeneous ESC-
derived retinal cell culture system.  
Consistent with this conclusion, we showed that sub-retinal transplantation of 
cells selected via the PPr biomarker panel (CD+) resulted in significantly higher 
integration levels compared to unsorted cells, or cells that did not label with the 
positive-selection markers (CD-). While integrated CD+ cells displayed the typical 
rod morphology and labeled with Recoverin, CD- cells rarely integrated and instead 
formed substantial cell masses with varying morphology. These observations 
illustrate heterogeneity present in the ESC retinal culture system and the effects of 
inclusion of non-photoreceptor cells in cell preparations. Significantly, we showed 
that the PPr biomarker panel selection excludes proliferating cells, as assessed by 
Ki67 labelling, even in samples comprising more than 10% mitotically active stem 
cells.  
This study brings together for the first time the use of photoreceptor cell sorting 
strategies using CD markers, and new ESC-derived self-forming retinal cultures to 
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isolate transplantation-competent cells without genetic modification. This is an 
important milestone towards the development of clinical photoreceptor cell therapy. 
The biomarker-sorted cells maintained viability and showed integration levels similar 
to those observed using genetically-labeled ESC-derived populations [22]. As the 
integration levels achieved with the ESC-derived cells and the PPr biomarker 
selection panel were lower than previously reported experiments using CD73/CD24 
selected cells (Median 10,899, range 544-32,826, [28]; Mean 2199 ± 1006 
cells/retina [9],) and Nrl.GFP selected cells (Mean 16,759 ± 1,705 cells/retina [13]), 
isolated from the developing retina, further optimization and fine tuning of 
differentiation and isolation protocols will be required to maximize the transplantation 
outcome. Variability in transplant outcomes as reflected in the range of integrated 
cell numbers, possibly due to variation in host inflammatory responses and surgical 
delivery of cells [14, 40, 41] also needs to be resolved in future studies. Based on 
our previous demonstration of restoration of visual function in the Gnat1−/− model 
containing ~25,000 newly-integrated cells from the developing retina [13], we 
estimate that a 40-fold increase in the number of integrating ESC-derived cells will 
be required to demonstrate robust restoration of rod function in a mouse model in 
vivo. 
Lastly, the fact that the expression of components of the photoreceptor 
biomarker panel was conserved in the developing and adult human retina suggests 
that our cell selection approach may be applicable for isolation of cells for clinical 
transplantation from human ESC/iPSC retinal culture systems. Taken together, we 
have identified and tested, for the first time, a set of 5 cell surface biomarkers that 
are useful for the enrichment of transplantation-competent rod photoreceptor cells 
from pluripotent stem cell-derived self-forming retina. These findings define an 
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approach that we anticipate will be broadly applicable for the isolation of 
photoreceptor cells for clinical therapy.  
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Figure legends 
 
Figure 1. Expression of the photoreceptor biomarker panel during retinal 
development in the mouse. (A) Representative FACS scatter plots showing co-
immunostaining of individual cell surface markers at different time point during retinal 
histogenesis. Dependent gates are shown from left to right. (B) Summary of FACS 
analysis for combined photoreceptor biomarker panel and CD73 alone. While CD73 
alone efficiently labels all post mitotic photoreceptor cells, including non-integration 
competent adult photoreceptors, the biomarker panel enriches for cells from a 
narrow postnatal time window, which coincides with transplantation competence. (C) 
Assessment of co-expression of retinal progenitor marker CD15 and CD73 at 
postnatal day 4. CD15 and CD73 are mutually exclusive during retinal development. 
(D) Schematic showing a comparison of the relative onset of expression of key 
photoreceptor markers and individual cell surface biomarkers. Vertical bars denote 
the optimal transplantation competent period for photoreceptor precursors (P4-P8).  
  
Figure 2. Characterization of PPr surface biomarkers on 3D ESC retinal cultures. 
(A, B) Day 12 optic vesicle neuroepithelium showing Vsx2 (green, A) and Pax6 (red, 
B) positive retinal progenitor cells. (C, D) Day 28 retinal neuroepithelium regions 
containing Rhodopsin (green, C) and Recoverin (red, D) positive ESC-derived 
photoreceptors. (E, F) Immunohistochemical analysis showing a small number of 
cells positive for Rod α-transducin (E) and Peripherin 2 (F) at day 28 of culture. High 
magnification inserts highlight expression pattern of these markers. (G) Real time 
quantitative RT-PCR analysis of ESC retinal cultures demonstrating the expression 
of PPr biomarker panel over time in culture. (H) Expression of the PPr biomarker 
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panel on day 26 FAC-sorted Rhop.GFP+ ESC-derived rods. (I) 
Immunohistochemical analysis for CD73, CD24, CD133 and CD47 (red), and 
Recoverin and Rhodopsin (green) on cryosections of ESC-retinal differentiations at 
day 12, 28 and 36 of culture. Scale bars: 25µm 
Figure 3. Expression of components of the photoreceptor biomarker panel during 
mESC differentiation. (A) Representative fluorescent activated cell sorting (FACS) 
scatter plots showing the expression of individual cell surface markers in 
undifferentiated mESC and at day 12 as well as day 27 of the retinal differentiation 
procedure. A summary of three experiments is shown to the right of the plots. (B) 
FACS analysis of PPr biomarker panel at day 12, 27 and 36 of mESC differentiation. 
At day 27 (scatter plots shown) about 25% of the cells in the differentiating embryoid 
bodies express the combination of cell surface markers characteristic for postnatal 
photoreceptors but do not co-label with progenitor marker CD15. By day 36 < 1% of 
total cell population expresses the PPr biomarker panel. FSC, forward scatter.  
Figure 4. Majority of CD73 positive cells in ESC-derived retinal cultures express 
photoreceptor markers. (A) Immunocytochemical analysis of cells from dissociated 
ESC retinal cultures co-stained with cell surface biomarker CD73 and photoreceptor 
markers Rhodopsin or Recoverin. Representative confocal tile scan of plated cells. 
Inset show high magnification view of indicated area. (B) Image analysis software 
Cellprofiler was used to determine the number of single or double positive cells from 
three independent experiments and confirmed by manual counting. Total number of 
marker positive cells is shown as light bars while darkly shaded bars indicate the 
percentage of cells co-staining for the respective second marker. About 44% of all 
cells express rhodopsin, 29% CD73 and 16% show Recoverin staining. The majority 
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of CD73 positive cells (~82%) label with rod photoreceptor marker rhodopsin and 
~40% label with Recoverin. (C) Analysis of cells selected from ESC-derived day 27 
retinal cultures using PPr biomarker panel (CD+). Immunocytochemical analysis of 
CD+ selected cells, CD- and unsorted ESC-derived cells with photoreceptor markers 
CRX, Rhodopsin or Recoverin was used to determine the number of cells expressing 
each marker (n= 3 independent experiments).  82.64 ± 7.53%, 76.83 ± 9.6%, and 
17.3 ± 4.9% of CD+ cells labelled with photoreceptor markers CRX, Rho, and REC 
respectively; Mean ± SD. Scale bars: 40 µm 
Figure 5. FAC-sorting via PPr biomarker panel eliminates mitotically active cells. (A) 
Representative FACS scatter plot of EdU based proliferation assay, following a 2 
hour EdU pulse, showing percentage of d26 ESC retinal culture cells in S-phase of 
cell cycle. Only 2% of cells have incorporated EdU demonstrating that the majority of 
ESC-derived cells are postmitotic. (B) Undifferentiated mESC (15%) were added to 
dissociated d26 retinal cultures and the resulting cell suspension was sorted via PPr 
biomarkers. CD(+), CD(-) and unsorted cells were plated for immunocytochemical 
analysis and the number of Ki67+ cells was determined using Cellprofiler software. 
(C) Summary of Ki67 based proliferation assay. FACS sorting using PPr biomarkers 
effectively removed Ki67+, mitotically active cells from the cell sample. FSC, forward 
scatter. DAPI, blue, Ki67, red. Scale bars: 200 µm 
Figure 6. Transplantation of mESC-derived, biomarker sorted photoreceptor 
precursors into the adult mouse retina. (A) Virally-labeled day 27 ESC-derived 
photoreceptor precursors sorted via biomarker panel integrated into Gnat1-/-adult 
retina. Anti-Gnat-1 immunohistochemistry only labels the outer segments of 
transplanted cells but not host photoreceptors. (B) Whole embryoid bodies from the 
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CBA.YFP mESC line endogenously expressing YFP; day 27 of retinal differentiation 
cultures were FAC-sorted via PPr biomarker panel and transplanted sub-retinally into 
adult wild-type retinas (B, C, D, E, F). (C, D) Cells expressing the biomarker panel 
(CD+) integrate into the outer nuclear layer (ONL) of the host, while cells from the 
biomarker negative fraction (CD-) did not integrate and formed large cell clusters in 
the subretinal space. (E) Summary of data from subretinal transplantation 
experiments showing numbers of cell integrates within the outer nuclear layer 3 
weeks post transplantation. (F) Transplanted cells, which have migrated into the 
ONL express photoreceptor marker Recoverin. Inset show a high magnification view 
of the area indicated by arrow. Scale bars, 20 µm. 
Figure 7. Expression of PPr biomarker panel components in the human retina. (A) 
RT-PCR analysis showing the expression of biomarkers at different stages of 
development in the human retina. CD24 and CD47 transcripts are strongly 
expressed prior to the F1 stage, while CD133 shows only weak levels of expression 
and CD73 is absent. CD73 transcripts are first observed at 11 weeks of gestation 
correlating with the onset of photoreceptor development. (B) Immunohistochemistry 
analysis of cell surface and key retinal markers at 19wk of gestation. CD24 and 
CD47 display a widespread expression pattern, labelling cells in all retinal layers. 
CD133 immunostaining is restricted to punctate labelling at the apical surface of the 
developing outer nuclear layer, whereas CD73 staining is absent at this stage. White 
arrows indicate region of higher magnification inset for CD133 and CD73. (C) 
Immunocytochemical analysis of 14 wk cultured fetal human cells. Cells expressing 
CD133, CD47 and CD24 are abundant at the beginning of culture, CD73 positive 
cells only begin to appear after two weeks in culture. (D) FACS analysis of cultured 
fetal cells at 14wk and adult human retinas. A small number of CD73/CD133 double 
Page 27 of 59
 28
positive cells are present in primary cell cultures derived from 14wk retinas. In the 
adult human retina ~78% of cells express CD73 and ~40% co-label with CD133, 
consistent with the murine retina. (E) Colabelling immunocytochemistry of 
dissociated adult retinal cells showing all CD73+ cells express the photoreceptor 
marker recoverin. ONL, outer nuclear layer; ONBL, outer neuroblastic layer; INL, 
inner nuclear layer; GCL, ganglion cell layer. Scale bars: 20 µm 
 
Supplementary Material 
Supplementary Table 1. CD surface marker analysis from P4 Nrl.GFP microarray. 
Genes encoding for cluster of differentiation (CD) markers expressed in the postnatal 
day 4 mouse retina. Genes are grouped according to their enrichment in the rod 
precursor population (Nrl.GFP+), other retinal cell types (Nrl.GFP-), or ubiquitous 
expression. The log intensity indicates relative signal strength in the microarray 
experiment and fold change is given as a measure of enrichment between positive 
and negative cell populations. A fold change value of 2 was used to delineate the 
two cell populations. Markers used in PPr biomarker panel are highlighted in green. 
 
Supplementary Figure 1. Cell surface marker screen of P8 Nrl.GFP retinae using 
BD Lyoplates. (A) Heat map showing top 15 cell surface marker candidates identified 
in the FACS-based screen. The relative number of cells in the Nrl.GFP positive and 
Nrl.GFP negative cell populations is indicated (red, high; green, low). (B) Individual 
flow cytometry scatter plots of dissociated P8 retinal cells for cell surface markers 
identified in the lyoplate screen. Nrl.GFP intensity is plotted on the x-axis whereas 
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staining intensity of the cell surface markers is shown on the individual y-axes. Top 
right hand quadrants of scatter plots show CD marker and Nrl.GFP co-labeled cells 
 
Supplementary Figure 2. A, Flow cytometry analysis of cell surface marker CD47 
during postnatal retinal development. At postnatal day 4 and 8, CD47 is expressed in 
most, if not all, retinal cells but is down-regulated in more mature Nrl.GFP expressing 
rod photoreceptors at day 21. B, Real time quantitative RT-PCR analysis of mouse 
retina demonstrating the expression of PPr biomarker panel over time. C, 
Immunohistochemical analysis for CD73, CD133, CD24, CD47, CD15, (red), on 
cryosections of P1, P7 and adult Nrl.GFP (green) retina.  CD73 and CD133 co-
localize in developing and mature photoreceptors, whereas initially broad expression 
of CD24 and CD47 is down-regulated in adult photoreceptors. CD15 is seen only in 
amacrine processes within the inner plexiform layer at these timepoints. NBL, 
neuroblastic layer; IPL, inner plexiform layer; GCL, ganglion cell layer; ONL, outer 
nuclear layer; INL, inner nuclear layer. Scale bars: 20µm. 
Supplementary Figure 3. A’-A’’’, Transplants of PPr biomarker panel selected cells 
from P8 mouse retina (Nrl.GFP) into wild type recipients. 3 weeks after subretinal 
injection, PPr selected GFP-positive photoreceptors were observed within the 
recipient ONL. B-D Immunohistochemical analysis of integrated rod photoreceptors 
derived from a YFP expressing mouse embryonic stem cell line and CD biomarker 
selected (CD+), 3 weeks after sub-retinal transplantation in wild-type mice. B-C, Z-
stack maximum projection showing integrated YFP-expressing photoreceptors co-
labelling with the rod specific phototransduction protein GNAT-1 in the host outer 
nuclear layer. Dashed square indicates the location of the high magnification image 
of a single slice of Z-stack. D, Low magnification view of CD+ transplanted cells 
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surviving in the subretinal space, corresponding to region shown in Figure 6E. White 
arrows in D' indicate the location of the inset high magnification image; location of 
asterisks in the inset plate correspond to the location of the arrows. IS, inner 
segment; OPL, outer plexiform layer; ONL, outer nuclear layer; INL, inner nuclear 
layer; Scale bars: 20µm  
Supplementary Figure 4. A, Immunohistochemical expression analysis of 
biomarkers in the developing and adult human retina. At 10, 13 and 19 weeks of 
gestation, CD24 and CD47 are expressed broadly across all retinal layers while 
CD133 is restricted to bright foci on the apical side of the outer neuroblastic layer 
abutting the retinal pigment layer. Immunostaining for CD73 on the other hand is not 
visible at these stages. At 19 weeks, CD24 and CD47 staining is particularly strong 
in the emerging inner plexiform layer, developing interneurons in the inner nuclear 
layer as well as nerve fibre layer. In the adult retina, CD73 expression can be 
observed in the ONL and CD133 is localized to the base of outer segments of 
photoreceptors. Both CD24 and CD47 are down regulated in the adult photoreceptor 
layer, while strong CD47 immuno-labelling is visible in the INL and OPL. By 10wks 
CD15 is down regulated in neuroblasts, and is detected transiently in projections of 
presumed amacrine cells in the IPL at 19wks. B, Real time quantitative RT-PCR 
analysis of the expression of the PPr biomarker panel over time in human retinal 
samples. CD24 and CD47 are downregulated in the adult retina compared with the 
fetal retina; expression patterns of the biomarkers during human and mouse retinal 
development are largely consistent (see Supplementary Figure 2). ONBL, outer 
neuroblastic layer; GCL, ganglion cell layer; INBL, inner neuroblastic layer; ONL , 
outer nuclear layer; INL, inner nuclear layer; IS, inner segments; OS, outer 
segments; IPL, inner plexiform layer. Scale bars 20µm 
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Material and Methods 
 
 
Animals  
Experimental mice were kept in University College London animal facilities 
and all experiments were conducted in agreement with the Animals (Scientific 
Procedures) Act 1986 and the Association for Research in Vision and 
Ophthalmology Statement for the Use of Animals in Ophthalmic and Vision 
Research. C57Bl/6J, and Gnat1−/− (kind gift of J. Lem; [1]) recipient mice were 
between 6 and 10 weeks of age at the time of transplantation.  
 
Mouse ES cell culture and 3D retinal differentiation 
The mouse EK.CCE ESC line [2] (129/SvEv; a kind gift of E. Robertson) or 
CBA.YFP ESC line (a variant of R1 ESCs; 7AC5/EYFP, from ATCC) were 
maintained as previously described [3]. On day 0 of retinal differentiation, 3 × 
104 ESCs were resuspended in one milliliter of differentiation medium (GMEM 
containing 1.5% KSR, 0.1 mM NEAA, 1 mM pyruvate, 0.1 mM 2-
mercaptoethanol) and plated into 96-well low-binding (Corning) plates. 
Embryoid-body cell aggregates were cultured at 37°C, 5% CO2 and growth 
factor-reduced Matrigel (BD Biosciences) was added on day 1 of retinal 
culture to a final concentration of 2% (v/v). At day 9, whole EBs were 
transferred into retinal maturation medium (DMEM/F12 Glutamax containing 
N2 supplement and Pen/strep), plated in low-binding plates at a density of 6 
wEBs/cm2 and maintained at 37 °C, 5% CO2. The media was changed every 
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 2–3 days and 1 mM taurine (Sigma) and 500 nM retinoic acid (Sigma) were 
added from day 14 of culture onward.  
 
Histology and Immunohistochemistry 
Tissue specimens were fixed in 4% (w/v) phosphate-buffered formaldehyde 
solution at 4°C for 30min, washed three times with phosphate-buffered saline 
(PBS) and equilibrated in 30 % (w/v) sucrose solution for cryo-protection at 
room temperature for 1-2 hours. Subsequently, the specimens were 
transferred into an optimal cutting temperature (OCT)-compound (RA Lamb) 
filled mould prior to freezing in a dry ice-methylbutane slurry. Tissue sections 
were prepared on a cryostat (Leica CM1900 UV) to 14-18 µm thickness and 
collected onto SuperfrostTM plus glass slides (VWR). OCT compound was 
removed by a 15 min incubation in 37 °C PBS. Tissue sections were then 
blocked with 10 % (v/v) goat serum, 1 % (w/v) bovine serum albumin (BSA) in 
PBS containing 0.1 % (v/v) Triton X-100 for one hour at room temperature 
preceding the primary antibody incubation. Triton X-100 was omitted for 
staining of cell surface molecules. The following primary antibodies were 
used; Recoverin, Millipore, 1:1000, overnight, 4°C; Cone arrestin, Millipore, 
1:20,000, overnight, 4°C; PKCa, Millipore, 1:1000, overnight, 4°C; Prominin 1, 
Biolegend, 1:350, overnight, 4°C. CD73 Biolegend 1:250, overnight, 4°C or 
CD24 BD Bioscience 1:250, overnight, 4°C). The primary antibody was 
omitted for negative controls. Primary antibody staining was followed by 
several washes with PBS. Tissue sections were then incubated for 1h at room 
temperature with the corresponding secondary antibody diluted in blocking 
solution (Goat anti-rabbit AlexaFluor594, Invitrogen, A-11037, 1:300; Donkey 
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 anti-sheep Cy3, Jackson, 1:500; Goat anti-mouse AlexaFluor594, Invitrogen, 
1:500). Hoechst 33342 (1:3000, Sigma-Aldrich) was applied for 10 min at 
room temperature to visualize nuclei, followed by three several washes with 
PBS prior to cover-slipping with the Citifluor AF-1 (Electron Microscopy 
Science) mounting medium. 
 
Dissociation of Retinal Cells/ESC retinal cultures and Flow Cytometry 
Neural retinae from wild-type eyes were isolated by micro-dissection and 
dissociated into a single cell suspension using enzymatic treatment with 
papain according to the manufacturer’s instructions (Worthington Biochemical, 
Lorne Laboratories, UK). In the case for mouse ESC cultures, differentiated 
whole embryoid bodies from day 12 and 27 of differentiation were used for 
analysis and treated similarly to retinal tissue. Eyes from a variety of 
developmental stages (E15.5, E17.5) and postnatal day, [P] 4, and [P] 8 as 
well adult were isolated and dissociated.  
 
Following dissociation cells were resuspended in FACS blocking buffer 
containing 1% BSA (w/v), phosphate-buffered saline and incubated for 45min 
on ice. The conjugated antibody or IgG isotype controls were added and cells 
were incubated in the dark on ice for additional 45min. The conjugated 
monoclonal antibodies were used for FACS analysis: PE-conjugated CD73 
(clone TY/11.8, eBioscience); Phycoerythrin-Cy7 conjugated CD24 (clone 
M1/69, BD Bioscience); PerCP-eFluor710 conjugated Prominin-1 (CD133, 
clone 13A4, eBioscience); AlexaFluor 647 conjugated CD47 (Biolegend, 
miap301); V450 conjugated CD15 (clone MC480, BD Horizon). Antibody 
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 specificity for these monoclonal antibodies including Western blot analysis 
has been previously demonstrated. The same antibody clones were used for 
FACS and immunohistochemistry analyses. FACS antibodies were used 
according to manufacturer’s instructions.  
 
After staining the cells were centrifuged at 200g for 5min at 4°C and 
resuspended in PBS and kept on ice until analysis. FACS analysis was 
carried out using a BD Bioscience LSR II flowcytometer and FlowJo software 
(Tree Star, USA). FACS gates were set according to specific isotype controls 
and at least 20000 events of live cells were analysed. FACS compensation 
was carried out using BD FACSDiva software using single stained controls for 
each conjugated antibody. Data presented is from at least 3 biological 
replicates.  
 
Immunocytochemistry on dissociated and FAC-sorted ESC-derived cells 
Day 27 ESC retinal cultures were dissociated and sorted via biomarker panel 
as described above. 50000 cells were plated on poly-lysine/laminin coated 
coverslips and allowed to adhere for 30min at 37C. Coverslips were then 
washed once with PBS and adherent cells fixed with 4% PFA/PBS for 10min 
at room temperature. Following three times washing with PBS, samples were 
blocking in 10% FBS, 1% BSA/ PBS containing 0.1 % (v/v) Triton X-100 for 1h 
at room temperature. The blocking solution was replaced by staining solution 
containing anti-Ki67 antibody in 10% FBS, 1% BSA/ PBS (0.1 % (v/v) Triton 
X-100). The primary antibody was omitted for negative controls. Finally 
coverslips with adherent cells were then incubated for 1h at room temperature 
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 with the secondary antibody diluted in blocking solution (Invitrogen, Goat anti-
rabbit AlexaFluor594) and counter stained 5min with DAPI. The percentage 
Ki67 positive cells in the experimental groups was established by Cellprofiler 
analysis software, using confocal tile scans and was verified by manual cell 
counts; > 100 cells were counted from 3 biological replicates for each 
condition. 
 
Microarray and lyoplate and screen for cell surface markers 
Postnatal day 4 Nrl.GFP microarray data were previously published [4] and 
deposited in the National Center for Biotechnology Information’s (NCBI; 
Bethesda, MD) Gene Expression Omnibus (GEO accession number E-MEXP-
3922). Array data were further analysed using Onto-express 
(http://vortex.cs.wayne.edu/ontoexpress/) and DAVID (Database for 
Annotation, Visualization and Integrated Discovery; 
http://david.abcc.ncifcrf.gov/home.jsp), in order to discover genes encoding 
cell surface CD markers.  
 
Retinal cell suspensions from P8 Nrl.GFP mice were prepared as described 
above and manufacturers recommendations were followed to conduct the 
antibody screen using lyoplates (BD). All centrifugation steps were carried out 
at 300g for 5min at 4°C. After retinal dissociation cells were resuspended in 
FACS staining buffer (BD) and adjusted to a cell concentration of 10 million 
cells per 1ml followed by transfer of the cell into round bottom 96-well plates 
(BD Falcon, Cat. No. 351177). 20 µl of reconstituted primary monoclonal 
antibody solution was then added to the cells, mixed and incubated on ice for 
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 30 minutes. This was followed by several washing steps with stain buffer (BD 
Pharmingen) after which the cells were incubated for 30 min with the 
appropriate biotinylated secondary antibody (rat, 1.25ug/ml; Syrian hamster, 
1.25ug/ml; Armenian hamster, 0.6ug/ml; mouse, 1.25ug/ml). Following 
several washing steps 100 µl of Alexa Fluor® 647 Streptavidin (1:4000, 
0.5ug/ml) was added to each well containing cells stained with the biotinylated 
secondary antibodies and incubated on ice in the dark for 30min. Finally, 
stained cells were washed several times and analysed on a BD FACSCalibur. 
At least 30,000 events were collected for the analysis using FACSDiva 
software and monoclonal antibodies were assessed for their ability to label 
Nrl.GFP positive rod precursors.  
 
Cell cycle analysis 
Click-iT EdU analysis was carried out according to manufacturer’s 
recommendations (Life Technologies). Briefly, whole day 27 embryoid body 
derived retinal cultures were incubated with 10uM EdU for 2h at 370C. Cells 
were harvested as described above (Dissociation of Retinal Cells/ ESC retinal 
cultures and Flow Cytometry) and blocked in 1% BSA in PBS. Cells were 
pelleted and 100ul fixative (4% PFA) was added followed by a 15min 
incubation at room temperature. The cells were then washed with 1% BSA in 
PBS, pelleted and re-suspended in 100ul of 1xClick-iT saponin based 
permeabilization and wash reagent. After 15min of incubation at room 
temperature 1x Click-iT reaction cocktail was added to the sample and 
incubated for 30min at room temperature followed resuspension in 
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 wash/permeabilization buffer. FACS analysis was carried out on a BD LSRII 
using unstained EdU negative cells as a control.   
 
For Ki67 assay day 27 ESC retinal cultures were dissociated and sorted via 
the biomarker panel as described above. 50000 cells were plated on poly-
lysine/laminin coated coverslips and allowed to adhere for 30min at 37oC. 
Coverslips were then washed once with PBS and adherent cells fixed with 4% 
PFA/PBS for 10min at room temperature. Following three times washing with 
PBS, samples were placed in blocking solution (10% FBS, 1% BSA/ PBS 
containing 0.1 % (v/v) Triton X-100) for 1h at room temperature. The blocking 
solution containing anti-Ki67 antibody was then added for 60 minutes at room 
temperature. The primary antibody was omitted for negative controls. Finally, 
coverslips with adherent cells were then incubated for 1h at room temperature 
with the secondary antibody diluted in blocking solution (Invitrogen, Goat anti-
rabbit AlexaFluor594) and counter stained for 5min with DAPI. The 
percentage Ki67 positive cells in the experimental groups was established by 
Cellprofiler analysis software, using confocal tile scans and was verified by 
manual cell counts. 
 
Retinal Cell Transplantations  
Donor cells for subretinal transplantation were derived from either CCE or 
ATCC-R mouse ESC lines, or from Nrl.GFP postnatal day 8 retinae (Nrl.GFP 
mice were a kind gift of A. Swaroop; [5]), and isolated as described above.  
For transplantation via PPr biomarkers, cells were incubated in blocking 
solution (1%BSA/PBS) for 1h and subsequently stained with specific 
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 monoclonal antibodies (see above) directed towards the biomarkers 
according to manufacturer’s recommendations or respective isotype controls. 
ESC-derived photoreceptor precursors were isolated by FAC-sorting (BD 
FACS AriaIII) with gating determined for each individual experiment using 
single stained controls and combined isotype controls. GFP/YFP fluorescence 
of donor cells was not taken into consideration for cell isolation. Cells in 
experimental group “unsorted” were processed identically to labelled cells 
except they were ungated. Post sort cell viability was > 85% based on DAPI 
staining, and the sorted cells were resuspended at 200,000 live cells/µl in 
injection buffer (EBSS, DNaseI) after centrifugation at 200g for 10min using a 
Heraeus Labfuge 400R (Thermos, UK).  
 
Recipient mice (6-8wk, C57Bl/6J or Gnat1-/-) were anaesthetised with an 
intraperitoneal injection of 0.2 ml of a mixture of Domitor (1 mg/ml 
(medetomidine hydrochloride, Pfizer Pharmaceuticals, Kent UK), ketamine 
(100 mg/ml, Fort Dodge Animal Health, Southampton, UK) and sterile water 
(ratio 5 : 3 : 42). Topical application of 1% tropicamide was used to dilate 
pupils of animals and injections were performed using a Zeiss operating 
microscope. Fundi were visualised using a contact lens system consisting of a 
coverslip and a drop of coupling medium liquid (Viscotears, Novartis 
Pharmaceuticals, Frimley, UK). The 34G injection needle loaded with 1 µl of 
cell suspension (containing 200,000 live FAC-sorted cells) was inserted under 
direct visualization through the superior equatorial sclera and guided into the 
sub-retinal space and towards the posterior pole, creating a self-sealing 
sclerotomy. Injection of the cell suspension in the superior hemisphere 
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 resulted in a bullous retinal detachment around the injection site. Anaesthesia 
was reversed by administration of 0.2ml of Antisedan (atipamezole 
hydrochloride 0.10 mg/ml, Pfizer, Kent UK). The retinas of recipient mice were 
harvested 3 weeks post cell transplantation and processed for analysis. 
 
Counts of integrated photoreceptors 
The number of integrated photoreceptor cells in the ONL of recipient retinae 
was established by counting serial sections of the eye. CBA.YFP cells with a 
cell body located within the ONL and displaying at least one of the following 
structures: inner/outer segment, inner/outer processes, synapse in the OPL, 
were scored as new integrated photoreceptors. The total number of integrated 
cells per eye was determined by counting all the integrated CBA.YFP+ cells in 
alternate serial sections through each eye. All transplanted eyes that 
contained CBA.YFP cells in the ONL and/or the sub retinal space were 
included in statistical analyses and all data points are represented in graphs. 
Mann Whitney tests were used to compare median integration efficiencies 
between samples. 
 
Microscopy, Image Acquisition, and Processing 
For epifluorescent analysis retinal sections were viewed on a Zeiss Axioplan 2 
and images captured using a Jenoptik C14 digital camera (OpenLab, 
Improvision). A Zeiss LSM710 (Zen2009, Zeiss) was used for acquisition of 
confocal micrographs. Images were processed in Zen2009 (Zeiss), 
Photoshop CS4 (Adobe), Illustrator CS4 (Adobe) and FIJI. Double-labelling 
analysis was carried out in Adobe Photoshop CS4. 
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Transcript analysis by quantitative Real-Time Polymerase Chain 
Reaction (qRT-PCR) 
Total RNA was extracted from retinal induced embryoid bodies or from FAC-
sorted cell populations using the RNeasy Mini Kit (Qiagen, UK). An on-column 
DNA digest was performed to eliminate all trace amounts of genomic DNA 
from the samples. Following quantification of total RNA using a NanoDrop 
ND-1000 spectrophotometer, cDNA was generated by means of M-MLV-
reverse transcriptase (Promega, USA). Gene expression levels were 
established for Nt5e, Cd24a, Cd47, Cd15 and Prom1 using Applied 
Biosystems Taqman PCR reagents and probes on a 7500 Real-Time PCR 
System according to manufacturer’s recommendations. Gene expression data 
was normalized using Gapdh as a reference. The mean RQ values as well as 
RQmin and RQmax as measures of variation were calculated using ABI 7500 
software 2.0.1. 
 
Human retinal cultures 
Human fetal retinal tissue was micro-dissected and dissociated using a 
papain solution according to manufacturer’s recommendation (Worthington 
Biochemical Corporation, Lorne Laboratories, UK). Cells were seeded on 
poly-L-lysine (Sigma-Aldrich) and laminin (Sigma-Aldrich, 1mg/ml) coated 
glass coverslips and cultured in retinal differentiation media containing 
DMEM-F12 Glutamax (Invitrogen), 1 x N2 and 1 x B27 neural supplements 
(Invitrogen) and 10% FBS (Invitrogen) as well as penicillin/streptomycin 
(Invitrogen). Cell culture media was changed every 2-3 days.  
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